Minsk protests against Ukraine's forced return to Kiev of Belavia planeWorld October 22, 14:05
Russian Foreign Ministry: Militants in Aleppo fail assistance delivery, civilians outflowsRussian Politics & Diplomacy October 22, 14:03
Kremlin: Syria’s breakup may become catastrophe for the regionRussian Politics & Diplomacy October 22, 14:00
Kremlin: Common language at Normandy Four talks is not oftenRussian Politics & Diplomacy October 22, 13:56
Kremlin: Extending humanitarian pause in Aleppo is Putin’s independent decisionRussian Politics & Diplomacy October 22, 13:50
Putin offered condolences to families of victims in Mi-8 crash in YamalSociety & Culture October 22, 11:20
Production of Russian flu vaccines in Nicaragua may start on October 22Society & Culture October 22, 7:44
Mascot of 2018 World Cup should be remembered like Olympic Mishka, Mutko saysSport October 22, 6:31
Nineteen people killed, 3 injured in helicopter crash landing in Russia's YamalSociety & Culture October 22, 5:00
MOSCOW, October 10 (Itar-Tass) — Russia’s ex-finance minister Alexei Kudrin insists that the country should invest more money into healthcare and less into defence.
“Russia still has to go down the path of increasing expenditures on healthcare. In this respect I would inject less into military needs than into healthcare,” he told the forum dealing with the Sixth Millennium Development Goal MDG-6 that opened in Moscow on Monday.
He reiterated his position saying that “an increase in military spending poses a threat to the support and development of healthcare and education programs.” “This is the reason of my conflict with the Russian incumbent president.”
In late September Alexei Kudrin resigned after a disagreement with President Dmitry Medvedev’s economic policy targeted at increasing expenditures on defence.
Speaking about reaching the development goals, mainly the goal to combat HIV/AIDS, malaria and other diseases, Kudrin stressed the need for creating a mechanism that would attract large pharmaceutical corporations to work in less developed countries and for the poor, as well-to-do people have access to most state-of-the-art medicines.